Atrioventricular Nodal Reentry Tachycardia (AVNRT) Treatment & Management

  • Author: Brian Olshansky, MD; Chief Editor: Jeffrey N Rottman, MD   more...
 
Updated: Feb 28, 2012
 

Medical Care

Management of an acute attack depends on the symptoms, the presence of underlying heart disease, and the natural history of previous episodes.

  • Rest, reassurance, and sedation may terminate the attack.
  • To terminate the tachycardia, try vagal maneuvers (eg, carotid sinus massage, exposure of the face to ice water, Valsalva maneuver) before initiating drug treatment. These maneuvers could also be tried after each pharmacological approach. Vagal maneuvers are unlikely to work and should not be tried if hypotension is present. Sometimes, putting the patient in the Trendelenburg position facilitates termination with a vagal maneuver.
  • Drugs that can be used to terminate an attack include adenosine, calcium channel blockers (eg, diltiazem, verapamil), beta-blockers, and digitalis.
    • Adenosine is typically the first-line agent used for rapid termination of AVNRT. In rare cases, the administration of adenosine, as well as other AV nodal blocking agents, may lead to ventricular fibrillation or even asystole for a short period of time. The mechanism by which adenosine could cause ventricular fibrillation would generally be due to transient block in the AV node and rapid antegrade conduction through an accessory pathway, should one exist. This almost never occurs and would only occur in the presence of atrial fibrillation. Defibrillation equipment must be readily available when adenosine is administered. For AVNRT, if present, adenosine will never initiate ventricular fibrillation in standard doses.
    • Adenosine administration should be given through a central large bore IV as it has a very short half-life. It should be followed by a saline flush and elevation of the extremity in which it is being injected.
    • Adenosine is the drug of choice for rapid termination of AVNRT. Rarely, administration of adenosine (and other agents capable of blocking the AV node) has been associated with the induction of ventricular fibrillation. Equipment for defibrillation should be available when adenosine is administered.
  • Direct current (DC) synchronized cardioversion is used to terminate an attack if the patient has hemodynamic compromise or if drug conversion fails and the patient continues to be symptomatic. DC cardioversion is rarely necessary for atrioventricular nodal reentry tachycardia (AVNRT).
  • Competitive atrial or ventricular pacing may be used if DC cardioversion is contraindicated (eg, if high doses of digitalis have been administered).
  • Preventive therapy is needed for frequent, prolonged, or highly symptomatic episodes that do not terminate spontaneously or those that cannot be easily terminated by the patient. Drugs that are used for prevention of recurrence include long-acting beta-blockers, calcium channel blockers, and digitalis. Radiofrequency catheter ablation[1] of the reentrant circuit should be considered in patients who have frequent or highly symptomatic episodes, who do not want drug therapy, who cannot tolerate the drugs, or in whom drug therapy fails.
Next

Surgical Care

No surgical procedure is indicated, but radiofrequency catheter ablation is associated with cure rates of greater than 95% with very low risk of atrioventricular block (< 1%) for patients with AVNRT.[1] Radiofrequency ablation is an invasive procedure in which catheter electrodes are placed percutaneously via central veins into the heart. Tachycardia can be initiated by pacing and by programmed electrical stimulation delivered from the atria or the ventricles. An ablation catheter electrode can be placed in the location of the slow AV nodal pathway and radiofrequency energy is delivered via the catheter to interrupt conduction via this pathway and thus eliminating the circuit.

Previous
Next

Consultations

  • Cardiologist
  • Electrophysiologist
Previous
Next

Diet

No specific recommendations or restrictions are necessary, but some patients' episodes are exacerbated by caffeine, theophylline, or theobromine in selected foods (coffee, tea, or chocolate, respectively). Alcohol may also be a trigger.

Previous
Next

Activity

Advise the patient to rest during tachycardia, preferably in a supine position.

Previous
Proceed to Medication
 
 
Contributor Information and Disclosures
Author

Brian Olshansky, MD  Professor of Medicine, Department of Internal Medicine, University of Iowa College of Medicine

Brian Olshansky, MD is a member of the following medical societies: American College of Cardiology, American Heart Association, Cardiac Electrophysiology Society, and Heart Rhythm Society

Disclosure: Guidant/Boston Scientific Honoraria Speaking and teaching; Medtronic Honoraria Speaking and teaching; Guidant/Boston Scientific Consulting fee Consulting

Coauthor(s)

Renee M Sullivan, MD  Fellow, Division of Cardiovascular Medicine, University of Iowa Hospitals and Clinics

Renee M Sullivan, MD is a member of the following medical societies: American College of Cardiology, American College of Physicians, and American Medical Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Russell F Kelly  MD, Assistant Professor, Department of Internal Medicine, Rush Medical College; Chairman of Adult Cardiology and Director of the Fellowship Program, Cook County Hospital

Russell F Kelly is a member of the following medical societies: American College of Cardiology

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Marschall S Runge, MD, PhD  Charles and Anne Sanders Distinguished Professor of Medicine, Chairman, Department of Medicine, Vice Dean for Clinical Affairs, University of North Carolina at Chapel Hill School of Medicine

Marschall S Runge, MD, PhD is a member of the following medical societies: American Association for the Advancement of Science, American College of Cardiology, American College of Physicians-American Society of Internal Medicine, American Federation for Clinical Research, American Federation for Medical Research, American Heart Association, American Physiological Society, American Society for Clinical Investigation, American Society for Investigative Pathology, Association of American Physicians, Association of Professors of Cardiology, Association of Professors of Medicine, Southern Society for Clinical Investigation, and Texas Medical Association

Disclosure: Pfizer Honoraria Speaking and teaching; Merck Honoraria Speaking and teaching; Orthoclinica Diagnostica Consulting fee Consulting

Amer Suleman, MD  Private Practice

Amer Suleman, MD is a member of the following medical societies: American College of Physicians, American Heart Association, American Institute of Stress, American Society of Hypertension, Federation of American Societies for Experimental Biology, Royal Society of Medicine, and Society of Cardiac Angiography and Interventions

Disclosure: Nothing to disclose.

Chief Editor

Jeffrey N Rottman, MD  Professor of Medicine and Pharmacology, Vanderbilt University School of Medicine; Chief, Department of Cardiology, Nashville Veterans Affairs Medical Center

Jeffrey N Rottman, MD is a member of the following medical societies: American Heart Association and North American Society of Pacing and Electrophysiology (NASPE)

Disclosure: Nothing to disclose.

Additional Contributors

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous coauthors Shamila Garg, MD, and Marina Hannen, MD, Chirag M Sandesara, MD, Mukesh Garg, MD, MRCP, Annette Quick, MD, and Marco A Barzallo, MD to the development and writing of this article.

References
  1. Jackman WM, Beckman KJ, McClelland JH, et al. Treatment of supraventricular tachycardia due to atrioventricular nodal reentry, by radiofrequency catheter ablation of slow-pathway conduction. N Engl J Med. Jul 30 1992;327(5):313-8. [Medline].

  2. Braunwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicine. 7th ed. Philadelphia, Pa: WB Saunders; 2004.

  3. Fogoros RN. Electrophysiologic Testing (Practical Cardiac Diagnosis). 3rd ed. London, UK: Blackwell Science; 1999.

  4. Gursoy S, Steurer G, Brugada J, et al. Brief report: the hemodynamic mechanism of pounding in the neck in atrioventricular nodal reentrant tachycardia. N Engl J Med. Sep 10 1992;327(11):772-4. [Medline].

  5. Janse MJ, Anderson RH, McGuire MA, Ho SY. "AV nodal" reentry: Part I: "AV nodal" reentry revisited. J Cardiovasc Electrophysiol. Oct 1993;4(5):561-72. [Medline].

Previous
Next
 
Electrophysiological mechanism of atrioventricular nodal reentry tachycardia.
Atypical atrioventricular nodal reentry tachycardia.
Typical atrioventricular nodal reentry tachycardia.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.